Could really go either way. They could be trying to figure out what’s gone wrong or results are better than expected and they want time to write something to publish. I’d be annoyed if all the time and money that’s been deployed for the phase 1b was all for nothing, but then why would they bother if they weren’t seeing decent results? I dunno but could be an interesting end to the year.
- Forums
- ASX - By Stock
- Clinical Trials
Could really go either way. They could be trying to figure out...
Featured News
Add CHM (ASX) to my watchlist
(20min delay)
|
|||||
Last
1.0¢ |
Change
0.000(0.00%) |
Mkt cap ! $9.951M |
Open | High | Low | Value | Volume |
1.1¢ | 1.1¢ | 1.0¢ | $30.25K | 3.010M |
Buyers (Bids)
No. | Vol. | Price($) |
---|---|---|
8 | 1600735 | 1.0¢ |
Sellers (Offers)
Price($) | Vol. | No. |
---|---|---|
1.1¢ | 545477 | 5 |
View Market Depth
No. | Vol. | Price($) |
---|---|---|
7 | 1300735 | 0.010 |
19 | 5134142 | 0.009 |
20 | 6501003 | 0.008 |
15 | 5983427 | 0.007 |
5 | 1744766 | 0.006 |
Price($) | Vol. | No. |
---|---|---|
0.011 | 545477 | 5 |
0.012 | 967491 | 4 |
0.013 | 153846 | 1 |
0.014 | 655016 | 2 |
0.015 | 579596 | 1 |
Last trade - 15.59pm 15/11/2024 (20 minute delay) ? |
Featured News
CHM (ASX) Chart |
The Watchlist
BTH
BIGTINCAN HOLDINGS LIMITED
David Keane, Co-Founder & CEO
David Keane
Co-Founder & CEO
Previous Video
Next Video
SPONSORED BY The Market Online